Adalimumab Appears Safe for Treating Pediatric Patients With Autoimmune Disease Adalimumab Appears Safe for Treating Pediatric Patients With Autoimmune Disease

Adalimumab appears to be safe for treating pediatric patients with polyarticular juvenile idiopathic arthritis (JIA), enthesitis-related arthritis (ERA), psoriasis and Crohn ' s disease (CD), according to data from company-sponsored clinical trials.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pediatrics News Source Type: news